GlassScriptPhysician profile
Michele Austin
NPI 1295402956
$1,159.61
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.81 · 2022: $269 · 2023: $221 · 2024: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.69 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $196.83 | 2022-2024 | Veozah |
| Daiichi Sankyo INC. | $164.04 | 2022-2024 | Injectafer, Vanflyta |
| Pfizer INC. | $134.82 | 2022-2024 | |
| Sage Therapeutics, LLC | $77.33 | 2024 | |
| Exeltis, USA INC. | $67.48 | 2021-2022 | |
| Shield Therapeutics INC | $66.48 | 2023-2024 | Accrufer |
| Sumitomo Pharma America, INC. | $58.95 | 2023-2024 | Gemtesa |
| Abbvie INC. | $58.09 | 2021-2023 | |
| Amgen INC. | $49.86 | 2022-2024 | Evenity, Prolia |
| Mayne Pharma Commercial LLC | $43.88 | 2024 | |
| Agile Therapeutics, INC. | $33.49 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $24.90 | 2024 | Gardasil, Gardasil 9 |
| Exact Sciences Corporation | $24.63 | 2023 | Cologuard Collection Kit |
| Novo Nordisk INC | $22.01 | 2023 | Wegovy |
| Ironwood Pharmaceuticals, INC | $20.68 | 2023 | Linzess |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $20.31 | 2024 | |
| Kedrion Biopharma, INC. | $18.82 | 2023 | Koate, Kedrab, Gammaked |
| Bayer Healthcare Pharmaceuticals INC. | $16.93 | 2022 | |
| Urovant Sciences INC | $16.55 | 2022 | |
| Cosette Pharmaceuticals INC. | $15.87 | 2024 | Vyleesi |
| Mylan Pharmaceuticals INC. | $15.19 | 2022 | |
| Davol INC. | $12.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Austin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.